Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Steven Rosenberg

Concepts (596)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Antigens, Neoplasm
57
2025
317
13.930
 Why?
Lymphocytes, Tumor-Infiltrating
62
2025
206
13.800
 Why?
Receptors, Antigen, T-Cell
55
2024
718
10.960
 Why?
Immunotherapy, Adoptive
53
2024
330
10.410
 Why?
T-Lymphocytes
47
2024
1983
7.290
 Why?
Melanoma
49
2024
763
7.090
 Why?
Neoplasms
35
2025
2712
5.300
 Why?
Gastrointestinal Neoplasms
8
2025
75
4.450
 Why?
CD8-Positive T-Lymphocytes
26
2023
912
3.840
 Why?
Autism Spectrum Disorder
22
2024
401
3.480
 Why?
Immunotherapy
16
2025
631
3.150
 Why?
Adoptive Transfer
18
2024
221
2.720
 Why?
Proto-Oncogene Proteins p21(ras)
8
2022
263
2.660
 Why?
Developmental Disabilities
13
2023
268
2.440
 Why?
Mutation
32
2025
3994
2.380
 Why?
Cancer Vaccines
8
2021
165
2.100
 Why?
Antigens, CD19
9
2022
123
2.040
 Why?
Programmed Cell Death 1 Receptor
9
2025
253
1.920
 Why?
CD4-Positive T-Lymphocytes
12
2022
1101
1.900
 Why?
Interleukin-2
7
2025
452
1.810
 Why?
Skin Neoplasms
13
2020
850
1.810
 Why?
Neoplasm Metastasis
18
2024
664
1.770
 Why?
Autistic Disorder
8
2024
205
1.720
 Why?
Humans
194
2025
138102
1.510
 Why?
ras Proteins
4
2021
150
1.430
 Why?
Colorectal Neoplasms
5
2025
817
1.360
 Why?
Neoplasm Proteins
7
2019
429
1.320
 Why?
Tumor Suppressor Protein p53
6
2022
524
1.260
 Why?
High-Throughput Nucleotide Sequencing
6
2025
541
1.230
 Why?
Epitopes, T-Lymphocyte
9
2021
185
1.190
 Why?
Eligibility Determination
3
2014
70
1.190
 Why?
Genetic Therapy
8
2022
310
1.140
 Why?
Lymphoma, B-Cell
4
2020
112
1.090
 Why?
Membrane Proteins
9
2019
1154
1.070
 Why?
Female
101
2025
73648
1.050
 Why?
Glioblastoma
2
2021
341
1.020
 Why?
Proto-Oncogene Proteins B-raf
4
2019
222
1.010
 Why?
Motor Skills Disorders
4
2016
29
0.990
 Why?
Child Development
7
2024
470
0.940
 Why?
Male
86
2025
67984
0.910
 Why?
Transcriptome
4
2022
969
0.900
 Why?
Middle Aged
56
2025
33509
0.890
 Why?
Genetic Engineering
6
2016
93
0.880
 Why?
HLA-A2 Antigen
11
2020
49
0.870
 Why?
Lymphoma, Large B-Cell, Diffuse
2
2017
123
0.870
 Why?
Gene Expression Regulation, Neoplastic
7
2019
1388
0.850
 Why?
Cell Line, Tumor
26
2021
3404
0.840
 Why?
Coronary Artery Disease
6
2017
701
0.810
 Why?
Flow Cytometry
9
2018
1194
0.790
 Why?
Precision Medicine
3
2015
420
0.790
 Why?
T-Lymphocyte Subsets
5
2019
419
0.770
 Why?
Tumor Microenvironment
2
2019
668
0.760
 Why?
Ovarian Neoplasms
2
2019
576
0.760
 Why?
Medicare Part C
2
2013
32
0.750
 Why?
Cell Separation
4
2019
316
0.730
 Why?
Adult
46
2025
38063
0.720
 Why?
Single-Cell Analysis
3
2022
324
0.710
 Why?
HLA-DP beta-Chains
3
2019
88
0.700
 Why?
Interleukin-12
3
2020
123
0.690
 Why?
Receptors, Antigen
3
2015
16
0.680
 Why?
Cognition Disorders
2
2016
504
0.660
 Why?
Aged
35
2025
23995
0.650
 Why?
Hematopoietic Stem Cell Transplantation
3
2022
625
0.650
 Why?
HLA-A Antigens
2
2021
57
0.650
 Why?
Receptors, Antigen, T-Cell, alpha-beta
4
2020
335
0.640
 Why?
Antigen Presentation
8
2020
220
0.630
 Why?
Retroviridae
2
2022
102
0.620
 Why?
Mutation, Missense
2
2020
340
0.620
 Why?
Interleukin-15
2
2017
101
0.620
 Why?
Colonic Neoplasms
2
2019
253
0.620
 Why?
Mucin-4
1
2019
4
0.610
 Why?
Smad5 Protein
1
2019
8
0.610
 Why?
Temperament
1
2019
45
0.600
 Why?
Exome
7
2016
234
0.600
 Why?
Lymphocyte Depletion
2
2016
136
0.600
 Why?
Immunity, Cellular
1
2020
270
0.590
 Why?
Child, Preschool
29
2024
11142
0.590
 Why?
T-Lymphocytes, Regulatory
2
2019
388
0.580
 Why?
Cholangiocarcinoma
2
2023
96
0.580
 Why?
Bile Duct Neoplasms
2
2023
118
0.570
 Why?
Sequence Analysis, DNA
2
2021
828
0.570
 Why?
ErbB Receptors
2
2019
609
0.560
 Why?
Disease Susceptibility
1
2019
348
0.530
 Why?
Genetic Vectors
5
2022
335
0.530
 Why?
Family Characteristics
2
2018
192
0.530
 Why?
Antigens
1
2019
356
0.520
 Why?
RNA, Messenger
3
2020
2799
0.520
 Why?
History, 20th Century
4
2025
325
0.520
 Why?
Child Behavior
1
2019
246
0.510
 Why?
Social Behavior
2
2023
289
0.510
 Why?
History, 21st Century
3
2025
213
0.500
 Why?
Myocardial Perfusion Imaging
2
2013
39
0.500
 Why?
Awards and Prizes
1
2017
72
0.500
 Why?
Transposases
1
2016
19
0.490
 Why?
Cell Engineering
1
2016
14
0.490
 Why?
Communication
2
2023
924
0.490
 Why?
Gene Expression Profiling
8
2019
1755
0.480
 Why?
Self-Injurious Behavior
4
2018
131
0.480
 Why?
Bile Ducts, Intrahepatic
2
2023
64
0.470
 Why?
Lymphoma
1
2017
210
0.470
 Why?
Cell Cycle Checkpoints
1
2016
97
0.470
 Why?
Psychotherapy
1
2017
177
0.470
 Why?
Immunologic Memory
5
2024
358
0.460
 Why?
Surveys and Questionnaires
9
2024
5850
0.440
 Why?
Breast Neoplasms
3
2022
2274
0.420
 Why?
T-Cell Antigen Receptor Specificity
7
2020
51
0.420
 Why?
Lymphocyte Transfusion
1
2013
21
0.420
 Why?
Lymphocytes
1
2016
392
0.420
 Why?
Lymphocyte Activation
10
2020
1146
0.410
 Why?
Sentinel Lymph Node Biopsy
1
2014
113
0.410
 Why?
Th1 Cells
1
2014
143
0.410
 Why?
Vidarabine
4
2017
33
0.410
 Why?
Indoles
1
2016
408
0.410
 Why?
Leukemia
2
2016
241
0.400
 Why?
Plaque, Atherosclerotic
1
2014
57
0.400
 Why?
Lymph Node Excision
1
2014
168
0.400
 Why?
Histocompatibility Antigens Class I
5
2021
203
0.400
 Why?
Animals
29
2024
37151
0.400
 Why?
Transplantation Conditioning
4
2019
173
0.390
 Why?
Sulfonamides
1
2016
510
0.390
 Why?
Child
22
2024
21990
0.390
 Why?
Cyclophosphamide
4
2017
241
0.390
 Why?
Melanoma, Experimental
4
2020
111
0.380
 Why?
Stem Cell Transplantation
1
2013
178
0.380
 Why?
Cell- and Tissue-Based Therapy
3
2019
82
0.380
 Why?
Transfection
1
2014
938
0.370
 Why?
Mice
21
2024
17769
0.370
 Why?
Gene Expression
7
2016
1487
0.360
 Why?
Genes, T-Cell Receptor
3
2022
9
0.360
 Why?
Antibodies, Monoclonal
3
2017
1419
0.350
 Why?
Melanoma-Specific Antigens
3
2016
5
0.350
 Why?
Adaptor Proteins, Signal Transducing
1
2014
430
0.350
 Why?
Biomarkers, Tumor
6
2019
1235
0.340
 Why?
Neoplasms, Second Primary
2
2022
114
0.340
 Why?
Coronary Angiography
5
2017
318
0.340
 Why?
Case-Control Studies
13
2024
3569
0.340
 Why?
Treatment Outcome
15
2021
10832
0.330
 Why?
Coculture Techniques
3
2021
240
0.330
 Why?
Transplantation, Autologous
3
2022
242
0.330
 Why?
United States
16
2025
15028
0.330
 Why?
Receptor, ErbB-2
4
2016
342
0.330
 Why?
Lung Neoplasms
3
2022
2571
0.320
 Why?
gp100 Melanoma Antigen
5
2016
8
0.320
 Why?
Medicaid
1
2014
439
0.320
 Why?
Papillomaviridae
3
2019
133
0.320
 Why?
Child Development Disorders, Pervasive
2
2024
62
0.320
 Why?
Kidney Neoplasms
1
2014
402
0.310
 Why?
Infant
11
2017
9566
0.310
 Why?
Transduction, Genetic
4
2019
136
0.300
 Why?
Papillomavirus Infections
3
2018
379
0.300
 Why?
Combined Modality Therapy
5
2021
1234
0.290
 Why?
Human papillomavirus 16
3
2018
33
0.290
 Why?
Peptides
4
2020
980
0.290
 Why?
Phenotype
6
2024
3158
0.290
 Why?
Prospective Studies
8
2023
7603
0.280
 Why?
Repressor Proteins
3
2017
423
0.280
 Why?
Intellectual Disability
3
2024
165
0.280
 Why?
Antigens, Differentiation, T-Lymphocyte
2
2020
97
0.280
 Why?
Tumor Necrosis Factor Receptor Superfamily, Member 9
3
2017
26
0.270
 Why?
Cells, Cultured
8
2021
4160
0.270
 Why?
Algorithms
3
2015
1711
0.260
 Why?
Prevalence
8
2018
2762
0.260
 Why?
Dendritic Cells
4
2019
491
0.260
 Why?
Carcinoma, Squamous Cell
3
2017
647
0.260
 Why?
Neoplasm Staging
5
2018
1371
0.260
 Why?
Oncogene Proteins, Viral
2
2017
22
0.250
 Why?
Tomography, X-Ray Computed
6
2018
2693
0.250
 Why?
Lymphocyte Count
2
2016
150
0.250
 Why?
Cell Proliferation
8
2019
2472
0.250
 Why?
Young Adult
13
2020
13329
0.250
 Why?
CD8 Antigens
2
2018
75
0.250
 Why?
Antineoplastic Combined Chemotherapy Protocols
2
2014
1702
0.240
 Why?
Antigens, CD
3
2020
530
0.240
 Why?
Uterine Cervical Neoplasms
4
2018
292
0.240
 Why?
Carcinoma
2
2018
229
0.230
 Why?
National Cancer Institute (U.S.)
1
2025
50
0.230
 Why?
Tumor Cells, Cultured
5
2018
946
0.230
 Why?
Pilot Projects
5
2019
1751
0.230
 Why?
Whole-Body Irradiation
2
2016
78
0.230
 Why?
Brain Neoplasms
4
2018
1267
0.220
 Why?
Socioeconomic Factors
3
2018
1312
0.220
 Why?
DNA Transposable Elements
2
2016
122
0.220
 Why?
Longitudinal Studies
5
2016
2861
0.220
 Why?
T-Lymphocytes, Cytotoxic
2
2015
174
0.220
 Why?
Jaundice, Neonatal
1
2023
8
0.210
 Why?
Sensitivity and Specificity
3
2018
1946
0.210
 Why?
Adolescent
13
2023
21637
0.210
 Why?
Immunohistochemistry
4
2016
1718
0.210
 Why?
Disability Evaluation
3
2014
297
0.210
 Why?
Leukocytes, Mononuclear
3
2015
568
0.200
 Why?
Infant, Very Low Birth Weight
2
2014
70
0.200
 Why?
Protein Engineering
2
2014
107
0.200
 Why?
Problem Behavior
2
2022
103
0.200
 Why?
Proto-Oncogene Proteins
2
2017
624
0.200
 Why?
Parks, Recreational
1
2022
11
0.190
 Why?
Constriction, Pathologic
2
2014
238
0.190
 Why?
Time-to-Treatment
1
2024
203
0.190
 Why?
DNA-Binding Proteins
3
2019
1477
0.190
 Why?
Occupational Therapy
2
2014
99
0.180
 Why?
Proteasome Endopeptidase Complex
2
2020
157
0.180
 Why?
HEK293 Cells
5
2017
730
0.180
 Why?
Burkitt Lymphoma
1
2022
60
0.180
 Why?
Clone Cells
2
2019
263
0.180
 Why?
Amino Acid Sequence
4
2020
2159
0.180
 Why?
Sex Factors
4
2017
2071
0.180
 Why?
Biomarkers
3
2019
4111
0.180
 Why?
Oncogenes
2
2020
118
0.180
 Why?
Adaptation, Psychological
2
2024
673
0.180
 Why?
Genes, Tumor Suppressor
2
2019
80
0.180
 Why?
Exercise Test
2
2015
621
0.180
 Why?
Genes, T-Cell Receptor alpha
1
2021
12
0.170
 Why?
Apyrase
1
2020
18
0.170
 Why?
Gene Expression Regulation
3
2019
2586
0.170
 Why?
Demography
3
2018
295
0.170
 Why?
Pancreatic Neoplasms
2
2022
851
0.170
 Why?
Cytokines
6
2022
2079
0.170
 Why?
Lectins, C-Type
1
2020
65
0.170
 Why?
Epitope Mapping
2
2018
61
0.170
 Why?
Oncolytic Virotherapy
1
2020
14
0.170
 Why?
MART-1 Antigen
3
2014
12
0.170
 Why?
HLA Antigens
2
2021
239
0.170
 Why?
Multiple Myeloma
1
2023
263
0.170
 Why?
Physical Therapy Modalities
2
2014
308
0.170
 Why?
Psychotropic Drugs
1
2021
72
0.170
 Why?
Mice, Mutant Strains
1
2020
306
0.160
 Why?
Lymphatic Metastasis
2
2019
322
0.160
 Why?
Models, Immunological
1
2020
101
0.160
 Why?
Drug Utilization
1
2021
169
0.160
 Why?
Premature Birth
1
2023
340
0.160
 Why?
HLA-C Antigens
2
2020
35
0.160
 Why?
Metastasectomy
2
2017
20
0.160
 Why?
Protein Binding
8
2020
2232
0.160
 Why?
Follow-Up Studies
7
2020
5144
0.160
 Why?
Remission Induction
5
2020
291
0.160
 Why?
Amino Acid Substitution
1
2020
307
0.160
 Why?
Virus Replication
1
2022
528
0.160
 Why?
Gene Regulatory Networks
1
2022
310
0.160
 Why?
Antibodies, Monoclonal, Humanized
1
2025
815
0.150
 Why?
Age Factors
3
2024
3285
0.150
 Why?
Genes, Neoplasm
1
2019
22
0.150
 Why?
Neoplasm Recurrence, Local
2
2017
1052
0.150
 Why?
Cysteine
1
2020
203
0.150
 Why?
Alcohol Oxidoreductases
1
2019
62
0.150
 Why?
Gestational Age
2
2024
915
0.150
 Why?
Practice Patterns, Physicians'
2
2021
1299
0.150
 Why?
Neoplasms, Glandular and Epithelial
1
2019
49
0.150
 Why?
Prognosis
6
2020
3982
0.150
 Why?
Area Under Curve
3
2014
306
0.150
 Why?
Cell Line
4
2022
2865
0.140
 Why?
Referral and Consultation
4
2023
797
0.140
 Why?
Neoplastic Cells, Circulating
1
2019
79
0.140
 Why?
B-Lymphocytes
3
2020
849
0.140
 Why?
Cohort Studies
6
2016
5731
0.140
 Why?
Trees
1
2018
73
0.140
 Why?
Behavior Therapy
1
2021
271
0.140
 Why?
RGS Proteins
1
2018
18
0.140
 Why?
Ubiquitin Thiolesterase
1
2018
48
0.140
 Why?
Medical Oncology
1
2020
301
0.140
 Why?
Education, Special
1
2017
24
0.140
 Why?
Forkhead Transcription Factors
1
2019
201
0.140
 Why?
Mothers
1
2024
765
0.140
 Why?
Smoking
2
2018
1616
0.140
 Why?
Psychometrics
2
2019
724
0.140
 Why?
Lymphoma, Non-Hodgkin
1
2018
86
0.140
 Why?
Parents
4
2022
1421
0.130
 Why?
Uveal Neoplasms
1
2017
10
0.130
 Why?
Tumor Necrosis Factor Ligand Superfamily Member 14
1
2017
3
0.130
 Why?
Self-Examination
1
2017
2
0.130
 Why?
Hematologic Neoplasms
1
2019
158
0.130
 Why?
Recombinant Fusion Proteins
3
2015
662
0.130
 Why?
Signal Transduction
5
2019
5068
0.130
 Why?
Societies, Scientific
1
2017
53
0.130
 Why?
ROC Curve
3
2013
563
0.130
 Why?
Maternal Age
1
2017
127
0.130
 Why?
Interferon-gamma
5
2020
788
0.130
 Why?
Immunologic Surveillance
1
2017
26
0.130
 Why?
Extracellular Signal-Regulated MAP Kinases
1
2017
174
0.130
 Why?
Administration, Intravenous
1
2017
153
0.130
 Why?
Carcinogenesis
1
2018
216
0.130
 Why?
Population Surveillance
2
2017
487
0.130
 Why?
fas Receptor
2
2015
96
0.130
 Why?
Disease Progression
5
2017
2730
0.130
 Why?
Tissue and Organ Procurement
1
2020
318
0.130
 Why?
CTLA-4 Antigen
1
2017
98
0.130
 Why?
Sialadenitis
1
2016
2
0.130
 Why?
Circulating Tumor DNA
1
2016
31
0.120
 Why?
WT1 Proteins
1
2016
15
0.120
 Why?
Peptidomimetics
1
2016
4
0.120
 Why?
Mitogen-Activated Protein Kinases
1
2017
315
0.120
 Why?
Logistic Models
4
2016
2081
0.120
 Why?
Antineoplastic Agents
2
2017
2125
0.120
 Why?
Green Fluorescent Proteins
2
2015
396
0.120
 Why?
HLA-DQ beta-Chains
1
2016
63
0.120
 Why?
ras GTPase-Activating Proteins
1
2015
15
0.120
 Why?
Urinary Bladder Neoplasms
1
2019
261
0.120
 Why?
Immunoglobulin A
1
2017
213
0.120
 Why?
Immunoglobulin M
1
2017
289
0.120
 Why?
Transplantation Chimera
1
2016
58
0.120
 Why?
Immunodominant Epitopes
1
2015
27
0.120
 Why?
Clonal Evolution
1
2016
45
0.120
 Why?
Coronary Vessels
2
2017
245
0.120
 Why?
Peer Group
1
2018
245
0.120
 Why?
Molecular Targeted Therapy
1
2019
407
0.120
 Why?
Proto-Oncogene Proteins c-akt
2
2015
442
0.120
 Why?
Cesarean Section
1
2017
187
0.120
 Why?
Psychoanalytic Therapy
1
1995
10
0.120
 Why?
T-Lymphocytes, Helper-Inducer
1
2016
138
0.120
 Why?
RNA, Neoplasm
1
2015
80
0.120
 Why?
Aged, 80 and over
3
2025
7638
0.120
 Why?
Receptors, HIV
1
2015
25
0.120
 Why?
Epitopes
2
2015
476
0.120
 Why?
Zinc Fingers
1
2015
49
0.120
 Why?
Leukemia, Lymphocytic, Chronic, B-Cell
1
2016
74
0.120
 Why?
Psychotherapy, Brief
1
1995
37
0.110
 Why?
Immunophenotyping
1
2016
324
0.110
 Why?
Sarcoma, Synovial
1
2014
22
0.110
 Why?
Alphapapillomavirus
1
2015
39
0.110
 Why?
Odds Ratio
2
2014
1077
0.110
 Why?
Immunity, Active
1
2014
11
0.110
 Why?
Neoplasms, Germ Cell and Embryonal
1
2016
78
0.110
 Why?
Receptor-Like Protein Tyrosine Phosphatases, Class 2
1
2014
10
0.110
 Why?
Language
1
2018
301
0.110
 Why?
Psychotherapy, Group
1
1995
74
0.110
 Why?
Endoribonucleases
1
2015
78
0.110
 Why?
Aspirin
1
2018
391
0.110
 Why?
Metalloproteins
1
2014
6
0.110
 Why?
Clinical Trials as Topic
5
2020
1032
0.110
 Why?
Managed Care Programs
1
1995
141
0.110
 Why?
Clinical Trials, Phase II as Topic
1
2014
71
0.110
 Why?
Hepatitis A Virus Cellular Receptor 2
1
2014
30
0.110
 Why?
Triple Negative Breast Neoplasms
1
2017
203
0.110
 Why?
5' Untranslated Regions
1
2014
58
0.110
 Why?
Nitric Oxide Synthase Type I
1
2014
30
0.110
 Why?
Thrombotic Microangiopathies
1
2014
20
0.110
 Why?
Echocardiography, Stress
1
2013
24
0.110
 Why?
Ribosomal Proteins
1
2014
92
0.110
 Why?
Tumor Lysis Syndrome
1
2013
8
0.110
 Why?
MAP Kinase Kinase Kinase 5
1
2013
6
0.110
 Why?
Mice, Transgenic
5
2020
2166
0.100
 Why?
Transcription Factors
2
2019
1709
0.100
 Why?
Autografts
1
2013
44
0.100
 Why?
Thioredoxins
1
2013
31
0.100
 Why?
HLA-DR4 Antigen
1
2013
76
0.100
 Why?
Policy Making
1
2014
99
0.100
 Why?
Testis
1
2014
156
0.100
 Why?
Motor Skills
1
2014
100
0.100
 Why?
Extremities
1
2014
135
0.100
 Why?
Carcinoma, Non-Small-Cell Lung
1
2022
1110
0.100
 Why?
Cross-Sectional Studies
5
2017
5556
0.100
 Why?
Health Care Reform
1
2014
108
0.100
 Why?
Cognition
2
2023
1173
0.100
 Why?
Gene Expression Regulation, Enzymologic
1
2014
276
0.100
 Why?
Allografts
1
2013
145
0.100
 Why?
Psychiatric Status Rating Scales
1
2015
551
0.100
 Why?
Transcriptional Activation
1
2015
373
0.100
 Why?
Immunoglobulin G
1
2017
901
0.100
 Why?
Astrocytoma
1
2013
127
0.100
 Why?
Interferon-alpha
1
2014
201
0.100
 Why?
Histones
1
2018
636
0.100
 Why?
Cell Movement
4
2019
971
0.100
 Why?
Nuclear Proteins
2
2015
709
0.100
 Why?
Likelihood Functions
1
2013
143
0.100
 Why?
Radiation Injuries
1
2014
147
0.100
 Why?
Nanotechnology
1
2013
124
0.100
 Why?
Esophageal Neoplasms
1
2016
317
0.090
 Why?
Proto-Oncogene Proteins c-bcl-2
1
2013
235
0.090
 Why?
Infant, Newborn
4
2023
6140
0.090
 Why?
Receptors, N-Methyl-D-Aspartate
1
2014
219
0.090
 Why?
Survival Rate
4
2020
1912
0.090
 Why?
Risk Factors
5
2023
10433
0.090
 Why?
Calcinosis
1
2014
235
0.090
 Why?
Muscle Proteins
1
2013
237
0.090
 Why?
Sarcoma
1
2014
189
0.090
 Why?
Cost of Illness
1
2014
303
0.090
 Why?
Propensity Score
1
2013
307
0.090
 Why?
Risk Assessment
3
2019
3471
0.090
 Why?
Killer Cells, Natural
1
2014
451
0.090
 Why?
Prostatic Neoplasms
1
2019
1055
0.090
 Why?
Randomized Controlled Trials as Topic
2
2013
1473
0.090
 Why?
Genome, Human
1
2013
419
0.090
 Why?
Research Design
2
2014
1122
0.090
 Why?
Anxiety
1
2018
1058
0.090
 Why?
Head and Neck Neoplasms
1
2016
554
0.090
 Why?
Wounds and Injuries
1
2018
758
0.080
 Why?
Health Policy
1
2014
397
0.080
 Why?
Cytotoxicity, Immunologic
3
2016
225
0.080
 Why?
Xenograft Model Antitumor Assays
3
2020
865
0.080
 Why?
RNA-Binding Proteins
1
2014
427
0.080
 Why?
Reverse Transcriptase Polymerase Chain Reaction
4
2014
979
0.080
 Why?
Genetic Testing
1
2013
458
0.080
 Why?
Decision Support Techniques
1
2013
422
0.080
 Why?
K562 Cells
2
2020
93
0.080
 Why?
Models, Theoretical
1
2013
583
0.080
 Why?
Time Factors
2
2017
6845
0.080
 Why?
HIV-1
1
2015
887
0.070
 Why?
Real-Time Polymerase Chain Reaction
3
2015
348
0.070
 Why?
Adenocarcinoma
1
2016
880
0.070
 Why?
Databases, Factual
3
2023
1381
0.070
 Why?
Colorado
2
2017
4553
0.070
 Why?
Protein Kinase Inhibitors
1
2014
905
0.070
 Why?
Coronary Stenosis
1
2008
38
0.070
 Why?
Arthritis, Rheumatoid
1
2017
1157
0.070
 Why?
RNA
1
2015
926
0.070
 Why?
Comorbidity
3
2018
1638
0.070
 Why?
Double-Blind Method
1
2013
1922
0.070
 Why?
Anti-HIV Agents
1
2015
836
0.070
 Why?
Apoptosis
2
2013
2555
0.070
 Why?
Neoplasm Transplantation
3
2015
250
0.070
 Why?
RNA, Small Interfering
3
2014
621
0.070
 Why?
Neutrophils
1
2013
1270
0.070
 Why?
Protective Factors
2
2017
95
0.060
 Why?
Faculty
1
2007
152
0.060
 Why?
Cross Reactions
2
2016
130
0.060
 Why?
DNA Mutational Analysis
2
2019
398
0.060
 Why?
Mass Screening
2
2020
1303
0.060
 Why?
Molecular Sequence Data
3
2015
2925
0.060
 Why?
Cardiovascular Diseases
1
2018
2121
0.060
 Why?
CD4 Antigens
2
2016
141
0.060
 Why?
Mice, Inbred C57BL
4
2020
5769
0.060
 Why?
Neutropenia
2
2017
154
0.060
 Why?
Mice, Inbred NOD
2
2018
597
0.060
 Why?
Retrospective Studies
5
2024
15750
0.060
 Why?
Single-Chain Antibodies
2
2015
17
0.060
 Why?
Protein Transport
2
2017
441
0.060
 Why?
Intercellular Junctions
2
2014
40
0.050
 Why?
Physical Examination
2
2017
243
0.050
 Why?
GPI-Linked Proteins
2
2014
76
0.050
 Why?
Parity
1
2024
128
0.050
 Why?
Lung
1
2016
4065
0.050
 Why?
Nerve Tissue Proteins
2
2020
596
0.050
 Why?
Receptor, Fibroblast Growth Factor, Type 2
1
2023
27
0.050
 Why?
Exercise
1
2015
2077
0.050
 Why?
Point Mutation
2
2014
238
0.050
 Why?
Health Facilities
1
2023
85
0.050
 Why?
Autoantigens
2
2016
423
0.050
 Why?
Bone Marrow
1
2023
299
0.050
 Why?
Minority Groups
1
2024
274
0.050
 Why?
Receptors, Cell Surface
1
2004
392
0.050
 Why?
Cluster Analysis
2
2014
515
0.050
 Why?
Linear Models
1
2024
861
0.050
 Why?
Skin
2
2019
753
0.050
 Why?
Alleles
2
2015
888
0.050
 Why?
Severity of Illness Index
2
2023
2838
0.040
 Why?
Oligonucleotide Array Sequence Analysis
2
2014
758
0.040
 Why?
Educational Status
1
2023
474
0.040
 Why?
Recombinant Proteins
2
2014
1349
0.040
 Why?
Proportional Hazards Models
1
2024
1265
0.040
 Why?
Parenting
1
2024
315
0.040
 Why?
Models, Genetic
2
2013
589
0.040
 Why?
Jurkat Cells
1
2020
138
0.040
 Why?
Predictive Value of Tests
2
2017
2029
0.040
 Why?
Base Sequence
2
2014
2180
0.040
 Why?
Immunoglobulins
1
2020
169
0.040
 Why?
Cysteine Endopeptidases
1
2020
73
0.040
 Why?
Glioma
1
2004
402
0.040
 Why?
Early Diagnosis
1
2020
238
0.040
 Why?
Cyclin-Dependent Kinase Inhibitor p16
1
2019
67
0.040
 Why?
Caregivers
2
2018
905
0.040
 Why?
Health Care Surveys
1
2021
565
0.040
 Why?
Hydrolysis
1
2019
194
0.040
 Why?
Fusion Regulatory Protein 1, Heavy Chain
1
2018
3
0.040
 Why?
GTP Phosphohydrolases
1
2019
92
0.040
 Why?
Protein Domains
1
2020
289
0.040
 Why?
GTP-Binding Protein alpha Subunits, Gi-Go
1
2018
18
0.040
 Why?
Cervix Uteri
1
2018
52
0.040
 Why?
Forests
1
2018
65
0.040
 Why?
Nuclear Localization Signals
1
2017
18
0.030
 Why?
Neoplasm Grading
1
2019
306
0.030
 Why?
Uterine Cervical Dysplasia
1
2018
44
0.030
 Why?
Mice, SCID
1
2018
368
0.030
 Why?
Disulfides
1
2018
98
0.030
 Why?
Healthcare Disparities
1
2024
662
0.030
 Why?
Hydrogen Bonding
1
2018
167
0.030
 Why?
Platelet Aggregation
1
2018
103
0.030
 Why?
Ligands
2
2013
666
0.030
 Why?
Eye Enucleation
1
2017
15
0.030
 Why?
Human papillomavirus 18
1
2017
16
0.030
 Why?
Response Evaluation Criteria in Solid Tumors
1
2017
18
0.030
 Why?
Protein Stability
1
2018
176
0.030
 Why?
GTP-Binding Protein alpha Subunits
1
2017
16
0.030
 Why?
GTP-Binding Protein alpha Subunits, Gq-G11
1
2017
20
0.030
 Why?
Culture Media, Serum-Free
1
2016
46
0.030
 Why?
Peptide Fragments
2
2015
691
0.030
 Why?
Lymphopenia
1
2017
64
0.030
 Why?
Drug Synergism
1
2017
369
0.030
 Why?
Vaccinia virus
1
2016
43
0.030
 Why?
Binding Sites
1
2020
1317
0.030
 Why?
Antigen-Presenting Cells
1
2017
158
0.030
 Why?
HLA-DRB1 Chains
1
2017
111
0.030
 Why?
Adenosine Triphosphate
1
2019
487
0.030
 Why?
Asymptomatic Diseases
1
2017
91
0.030
 Why?
Salivary Glands, Minor
1
2016
11
0.030
 Why?
Tissue Array Analysis
1
2016
51
0.030
 Why?
Blood Chemical Analysis
1
2017
109
0.030
 Why?
Health Surveys
1
2018
523
0.030
 Why?
Cell Membrane
1
2020
713
0.030
 Why?
Neoplasm Invasiveness
1
2018
498
0.030
 Why?
Leukemia, B-Cell
1
2016
13
0.030
 Why?
Radiotherapy
1
2017
206
0.030
 Why?
Fas Ligand Protein
1
2015
59
0.030
 Why?
HLA-A1 Antigen
1
2015
4
0.030
 Why?
Palate
1
2016
38
0.030
 Why?
Antigen-Antibody Reactions
1
2015
55
0.030
 Why?
Genes, erbB-2
1
2015
28
0.030
 Why?
Feasibility Studies
1
2020
971
0.030
 Why?
Salvage Therapy
1
2016
139
0.030
 Why?
Machine Learning
1
2021
516
0.030
 Why?
MAP Kinase Signaling System
1
2017
322
0.030
 Why?
Anemia
1
2017
171
0.030
 Why?
Interferon-gamma Release Tests
1
2015
32
0.030
 Why?
Anus Neoplasms
1
2015
34
0.030
 Why?
Health Promotion
1
2022
759
0.030
 Why?
Compulsive Behavior
1
2015
7
0.030
 Why?
Thrombocytopenia
1
2017
198
0.030
 Why?
DNA, Neoplasm
1
2015
158
0.030
 Why?
Necrosis
1
2016
247
0.030
 Why?
Coronary Occlusion
1
2015
19
0.030
 Why?
Cloning, Molecular
1
2016
535
0.030
 Why?
Gastrointestinal Diseases
1
2017
207
0.030
 Why?
HIV Envelope Protein gp120
1
2015
61
0.030
 Why?
Dermatitis
1
2014
19
0.030
 Why?
HIV Antibodies
1
2015
61
0.030
 Why?
Metabolic Clearance Rate
1
2014
107
0.030
 Why?
Desmoplakins
1
2014
21
0.030
 Why?
Income
1
2016
204
0.030
 Why?
Regression Analysis
1
2017
1012
0.030
 Why?
Protein Conformation
1
2018
944
0.030
 Why?
Transplantation, Homologous
1
2016
412
0.030
 Why?
Granulocyte-Macrophage Colony-Stimulating Factor
1
2015
151
0.030
 Why?
Monophenol Monooxygenase
1
2014
8
0.030
 Why?
Comparative Genomic Hybridization
1
2014
29
0.030
 Why?
Nausea
1
2014
111
0.030
 Why?
Cell Survival
1
2017
1130
0.030
 Why?
Models, Statistical
1
2018
665
0.030
 Why?
Mice, Inbred BALB C
1
2017
1260
0.030
 Why?
Gene Library
1
2014
119
0.030
 Why?
National Institutes of Health (U.S.)
1
2014
130
0.030
 Why?
Random Allocation
1
2014
362
0.030
 Why?
MAP Kinase Kinase 4
1
2013
24
0.030
 Why?
Histocompatibility Antigens
1
2014
106
0.030
 Why?
Infusions, Intravenous
1
2014
399
0.030
 Why?
Substrate Specificity
1
2014
385
0.030
 Why?
Social Class
1
2016
282
0.030
 Why?
Graft vs Host Disease
1
2016
252
0.030
 Why?
Sleep Wake Disorders
1
2017
301
0.030
 Why?
X-Ray Diffraction
1
2013
104
0.030
 Why?
Tumor Burden
1
2014
306
0.030
 Why?
Lentivirus
1
2013
59
0.030
 Why?
Confidence Intervals
1
2014
334
0.030
 Why?
Radiotherapy, Adjuvant
1
2014
214
0.030
 Why?
Immunoenzyme Techniques
1
2013
208
0.030
 Why?
Immunoprecipitation
1
2013
152
0.030
 Why?
Fever
1
2014
306
0.030
 Why?
Structure-Activity Relationship
1
2014
568
0.020
 Why?
Health Services Accessibility
1
2021
996
0.020
 Why?
Reproducibility of Results
2
2012
3301
0.020
 Why?
Drug Administration Schedule
1
2014
753
0.020
 Why?
Models, Molecular
1
2018
1598
0.020
 Why?
Cotinine
1
2012
77
0.020
 Why?
Bias
1
2013
224
0.020
 Why?
Cost-Benefit Analysis
1
1995
585
0.020
 Why?
Histocompatibility Antigens Class II
1
2014
366
0.020
 Why?
DNA Primers
1
2013
508
0.020
 Why?
Receptors, Immunologic
1
2013
215
0.020
 Why?
Spleen
1
2014
521
0.020
 Why?
Bayes Theorem
1
2013
410
0.020
 Why?
Pregnancy
1
2023
6789
0.020
 Why?
Blotting, Western
1
2013
1223
0.020
 Why?
Liver Neoplasms
1
2017
759
0.020
 Why?
Diagnosis, Differential
1
2015
1490
0.020
 Why?
Multivariate Analysis
1
2014
1495
0.020
 Why?
Carrier Proteins
1
2014
738
0.020
 Why?
Dose-Response Relationship, Drug
1
2014
2022
0.020
 Why?
Kinetics
1
2013
1640
0.020
 Why?
Tumor Necrosis Factor-alpha
1
2015
1239
0.020
 Why?
Phosphorylation
1
2014
1760
0.020
 Why?
Infant, Premature
1
2014
580
0.020
 Why?
North Carolina
1
2008
118
0.020
 Why?
Germany
1
2008
125
0.020
 Why?
Self Report
1
2012
838
0.020
 Why?
Cell Differentiation
1
2015
1999
0.020
 Why?
Disease Models, Animal
1
2018
4309
0.020
 Why?
Vaccination
1
2016
1431
0.020
 Why?
Models, Biological
1
2014
1784
0.020
 Why?
MicroRNAs
1
2013
678
0.020
 Why?
Intelligence
1
2007
129
0.020
 Why?
Polymorphism, Single Nucleotide
1
2013
2145
0.010
 Why?
Receptors, Urokinase Plasminogen Activator
1
2004
15
0.010
 Why?
Urokinase-Type Plasminogen Activator
1
2004
29
0.010
 Why?
Transplantation, Heterologous
1
2004
195
0.010
 Why?
Species Specificity
1
2004
584
0.010
 Why?
Neovascularization, Pathologic
1
2004
296
0.010
 Why?
Mice, Nude
1
2004
690
0.010
 Why?
Down Syndrome
1
1987
486
0.010
 Why?
Polyethylene Glycols
1
2004
632
0.010
 Why?
Endothelium, Vascular
1
2004
934
0.010
 Why?
Rosenberg's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (596) concept(s)
_
Co-Authors Expand Description
See all (11) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)